Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Prestwick3_000542

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Prestwick3_000542

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 104Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sobi & Horizon enter five-year distribution agreement for Ravicti & Ammonaps
    Sobi & Horizon enter five-year distribution agreement for Ravicti & Ammonaps

    07 Dec 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/sobi-and-horizon-pharma-enter-five-year-distribution-agreement-for-ravicti-and-ammonaps-outside-the-united-states-300374421.html

    PR NEWSWIRE
    07 Dec 2016
    Share Share
    District Court Sides with FDA, 505(b)(2) Applicant in Challenge to Colchicine Capsules Approval; An Appeal is in the Works, However
    District Court Sides with FDA, 505(b)(2) Applicant in Challenge to Colchicine Capsules Approval; An Appeal is in the Works, However

    12 Jan 2015

    // Kurt R. Karst FDA LAW BLOG

    http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2015/01/district-court-sides-with-fda-505b2-applicant-in-challenge-to-colchicine-capsules-approval-an-appeal.html

    Kurt R. Karst FDA LAW BLOG
    12 Jan 2015
    Share Share